Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Anopheles stephensi

- PMLiVE

Merck Serono signs agreement to develop antimalarial therapy

Deal means the German firm obtains rights to candidate DDD107498

- PMLiVE

Novartis brings creative malaria campaign to Pinterest

Invites users to create their own mosquito-killing story

Novartis building

Novartis to deliver three million malaria treatments in Zambia

Part of Malaria No More’s Power of One campaign

- PMLiVE

Sanofi ships synthetic malaria jab

French manufacturer says Gates Foundation-funded venture could widen treatment

Novartis building

Novartis: novel antimalarial is ‘game-changing’

Says cipargamin could be first new class of malaria drugs in 20 years

dengue fever mosquito

GSK seeks approval for first malaria vaccine

Submits marketing application to European Medicines Agency

EU flag

Europe extends clinical trial project with African researchers

Partnership has already developed eight improved medical treatments

Novartis building

Scientists finds new drug target for malaria

Novartis and academics identify new class of medicines to treat all stages of infection

- PMLiVE

GSK hoping to file malaria vaccine next year

New phase III data backs submission plans

- PMLiVE

Malaria vaccine gives “unprecedented” results

Able to protect 12 out of 15 people in phase I trial

- PMLiVE

Video for neglected tropical diseases challenges viewers

Non-profit organisation END7 asks: 'Can you watch what they watched?'

- PMLiVE

Sanofi’s four-strain flu vaccine Vaxigrip under review in EU

Pharma company also launches production of ingredient for malaria drug

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links